<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for LGND</title>
    <link />
    <description>Headlines for Ligand Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Ligand to Present at Upcoming Investor Conferences</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/23/ligand-to-present-at-upcoming-investor-conferences/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 23 May 2013 08:51:48 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Pharmaceuticals Inc. Stock Upgraded (LGND)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11923727/1/ligand-pharmaceuticals-inc-stock-upgraded-lgnd.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 05:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/ligand-partner-rib-x-initiates-phase-3-trial-of-ca/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 09:06:18 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3586956/ligand-partner-rib-x-initiates-phase-3-trial-of-captisol-enabled-delafloxacin-iv.aspx</link>
      <author>Benzinga</author>
      <pubDate>Tue, 14 May 2013 08:33:39 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Pharmaceuticals Incorporated Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1416441-ligand-pharmaceuticals-incorporated-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 18:50:09 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Reports First Quarter Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/08/ligand-reports-first-quarter-financial-results/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 08 May 2013 16:25:30 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Announces $5M Buyback, Q1 Earnings</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3572230/ligand-announces-5m-buyback-q1-earnings.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 08 May 2013 16:14:03 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/30/ligand-acquires-financial-rights-to-more-than-15-f/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 30 Apr 2013 06:05:24 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3516203/stocks-hitting-52-week-highs.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 22 Apr 2013 10:34:56 GMT</pubDate>
    </item>
    <item>
      <title>Several Big Growth Stories In Biotech: Keith Markey</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1308521-several-big-growth-stories-in-biotech-keith-markey.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Mar 2013 20:13:07 GMT</pubDate>
    </item>
    <item>
      <title>SPPI Acquires Late-Stage Candidate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95049/sppi-acquires-late-stage-candidate.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 18 Mar 2013 18:20:01 GMT</pubDate>
    </item>
    <item>
      <title>3D Systems Scrutiny Highlights Promise For 3D Bioprinting</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1274351-3d-systems-scrutiny-highlights-promise-for-3d-bioprinting.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Mar 2013 13:43:47 GMT</pubDate>
    </item>
    <item>
      <title>Why Ligand Pharmaceuticals Is Poised to Pull Back</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/14/why-ligand-pharmaceuticals-is-poised-to-pull-back/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 14 Mar 2013 10:48:00 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Signs Global License Agreement with Spectrum Pharmaceuticals for Captisol-Enabled® Melphalan</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/14/ligand-signs-global-license-agreement-with-spectru/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 14 Mar 2013 07:15:54 GMT</pubDate>
    </item>
    <item>
      <title>Ligand,  Spectrum Pharmaceuticals in Global License Agreement</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3415904/ligand-spectrum-pharmaceuticals-in-global-license-agreement.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 14 Mar 2013 07:02:49 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Receives $1.4 Million Milestone Payment from Retrophin, Inc.</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/25/ligand-receives-14-million-milestone-payment-from-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 25 Feb 2013 14:20:26 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Pharmaceuticals Inc. Stock Downgraded (LGND)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11844075/1/ligand-pharmaceuticals-inc-stock-downgraded-lgnd.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 18 Feb 2013 04:00:00 GMT</pubDate>
    </item>
    <item>
      <title>LIGAND PHARMACEUTICALS INCORPORATED CEO discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1182361-ligand-pharmaceuticals-incorporated-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 13 Feb 2013 21:44:04 GMT</pubDate>
    </item>
    <item>
      <title>Ligand Reports Fourth Quarter and Full Year 2012 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/13/ligand-reports-fourth-quarter-and-full-year-2012-f/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 13 Feb 2013 16:25:58 GMT</pubDate>
    </item>
    <item>
      <title>5 Hated Stocks Set to Soar on Earnings</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-hated-stocks-set-soar-earnings.html-5.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 12 Feb 2013 12:42:00 GMT</pubDate>
    </item>
  </channel>
</rss>
